REAL WORLD STUDY
Clinical trials for REAL WORLD STUDY explained in plain language.
Never miss a new study
Get alerted when new REAL WORLD STUDY trials appear
Sign up with your email to follow new studies for REAL WORLD STUDY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-World trial tests immunotherapy for advanced lung cancer
Disease control Recruiting nowThis study is observing how well the immunotherapy drug atezolizumab works as the first treatment for people with stage IV non-small cell lung cancer that has high PD-L1 levels and no targetable gene changes. About 150 participants will be followed in regular clinic settings to s…
Matched conditions: REAL WORLD STUDY
Sponsor: Antalya Training and Research Hospital • Aim: Disease control
Last updated May 17, 2026 02:27 UTC
-
New hope for lung cancer patients who fail current therapy
Disease control Recruiting nowThis study is testing a drug called iruplinalkib in people with advanced ALK-positive lung cancer who have already tried and stopped responding to lorlatinib. Researchers want to see if iruplinalkib can help control the cancer and how safe it is. About 20 adults will take part, a…
Matched conditions: REAL WORLD STUDY
Sponsor: Peking University Shenzhen Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
500 ICU patients tracked to uncover why some survive severe lung failure
Knowledge-focused Recruiting nowThis study follows 500 people in intensive care with Acute Respiratory Distress Syndrome (ARDS), a severe lung injury that makes breathing very difficult. Researchers will collect data from medical records, scans, and blood tests to find factors that predict survival or complicat…
Matched conditions: REAL WORLD STUDY
Sponsor: Ming Zhong • Aim: Knowledge-focused
Last updated May 17, 2026 02:41 UTC
-
4,700 kidney cancer records mined to build smarter treatment predictor
Knowledge-focused Recruiting nowThis study looks back at medical records from 4,700 kidney cancer patients treated between 2012 and 2024. The goal is to create a tool that can predict how the disease will progress and help doctors choose the best treatment for each patient. No new drugs or treatments are being …
Matched conditions: REAL WORLD STUDY
Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated May 08, 2026 12:02 UTC